Flora Growth (Flora Growth) Gross Margin % : 19.42% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Flora Growth Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Flora Growth's Gross Profit for the three months ended in Dec. 2023 was $3.49 Mil. Flora Growth's Revenue for the three months ended in Dec. 2023 was $17.98 Mil. Therefore, Flora Growth's Gross Margin % for the quarter that ended in Dec. 2023 was 19.42%.

The historical rank and industry rank for Flora Growth's Gross Margin % or its related term are showing as below:

FLGC' s Gross Margin % Range Over the Past 10 Years
Min: 23.25 Med: 33.34 Max: 66.98
Current: 23.25

During the past 5 years, the highest Gross Margin % of Flora Growth was 66.98%. The lowest was 23.25%. And the median was 33.34%.

FLGC's Gross Margin % is ranked worse than
84.76% of 991 companies
in the Drug Manufacturers industry
Industry Median: 46.47 vs FLGC: 23.25

Flora Growth had a gross margin of 19.42% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Flora Growth was 0.00% per year.

Flora Growth Gross Margin % Historical Data

The historical data trend for Flora Growth's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth Gross Margin % Chart

Flora Growth Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

66.98

27.00

39.67

23.32

Flora Growth Quarterly Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial										28.64	27.24	18.45	28.54	19.42

Competitive Comparison of Flora Growth's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Flora Growth's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Flora Growth's Gross Margin % falls into.

Flora Growth Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Flora Growth's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	17.7	/	76.071
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(76.071 - 58.333)	/	76.071
	=	23.32 %

Flora Growth's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	3.5	/	17.975
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(17.975 - 14.485)	/	17.975
	=	19.42 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Flora Growth (NAS:FLGC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Flora Growth had a gross margin of 19.42% for the quarter that ended in Dec. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Flora Growth Gross Margin % Related Terms

Thank you for viewing the detailed overview of Flora Growth's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Flora Growth (Flora Growth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (NAS:FLGC) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132

Website

https://www.floragrowth.com

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company operates in the United States, Germany, Colombia, the United Kingdom, and Canada. it derives a majority of its revenue from the United States.

Executives

Thomas Solomon	director	C/O FLORA GROWTH CORP., 365 BAY STREET; SUITE 800, TORONTO Z4 M5H 2V1
Kevin Taylor	director	C/O COOL HOLDINGS, INC., 2001 NW 84TH AVENUE, MIAMI FL 33122
Hussein Rakine	director, officer: Chief Executive Officer	5258 SW 183RD AVENUE, MIRAMAR FL 33029
Clifford Starke	director, officer: President	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Edward Woo	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
John Timothy Leslie	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Marc Mastronardi	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jason Warnock	officer: CCO	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Annabella Manalo Morgan	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jessie Casner	officer: CMO	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Dany Vaiman	officer: Sr. VP Finance	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Elshad Garayev	officer: CFO	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Beverley Richardson	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Roa Juan Carlos Gomez	director	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Luis Merchan	director, officer: CEO & Chairman of the Board	C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312